<DOC>
	<DOCNO>NCT00273468</DOCNO>
	<brief_summary>To study safety effectiveness granisetron patch treat Chemotherapy-Induced Nausea Vomiting ( CINV )</brief_summary>
	<brief_title>To Study Safety Effectiveness Granisetron Patch Treat Chemotherapy-Induced Nausea Vomiting ( CINV )</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Granisetron</mesh_term>
	<criteria>Patients must nonchildbearing potential female patient must negative pregnancy test Screening Visit Histologically and/or cytologically confirm cancer ECOG ≤2 Life expectancy ≥ 3 month Assigned receive first cycle new multiday chemotherapy regimen include daily administration cytotoxic agent ( ) emetogenic potential level 35 ( Hesketh Classification ) 35 day Hypersensitivity adhesive plaster Contraindications 5HT3 receptor antagonist Clinically relevant abnormal laboratory value hepatic , renal , infectious , neurological psychiatric disorder major systemic illness discretion Investigator Any cause nausea vomit CINV Clinically relevant abnormal ECG parameter Concomitant radiotherapy total body , brain upper abdomen within one week study entry plan study A patient take medication control symptoms brain tumour , brain metastasis seizure disorder</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>